Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

R1 RCM Inc. (RCM): Midwood Capital Management Keeps It As The Top Position

Midwood Capital Management posted a 10.6% return for the first three months of 2019 in its Q1 2019 Investor Letter (download here). The fund also shared its annualized return since inception, which amounted to 9.5%, and posted a few short comments on several stocks in its equity portfolio. For its largest position,  R1 RCM Inc. (NASDAQ:RCM), and one of the biggest contributors to its quarterly performance, the fund said the following:

“R1 RCMInc. (RCM;$10.04; $2.6billion market cap): This leading independent provider of revenue cycle management services to acute care hospitals and physician groups remains our largest position. The stock traded idiosyncratically in January despite providing very bullish guidance early in the month ahead of the bellwether J.P. Morgan Healthcare Conference. The stock began to make a move upward at the end of January, ultimately rising nearly 22% in the first quarter. RCM contributed 353 bps to the Fund’s gross return in Q1”

16 Most Technologically Advanced Countries in the World in 2017

everything possible/Shutterstock.com

R1 RCM is a $1.19 million market cap revenue cycle management company that provides its professional services to hospitals and physician group in the US. Over the last six months, its stock gained 22.48%, and on May 7th it had a closing price of $10.73.

For the full year 2018, the company reported $868.5 million revenue and diluted loss per share of $0.60, compared to revenue of $418.7 million and diluted loss per share of $0.75 for the full year  2017.

Dislcosure: None.
This article is originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...